SUBSCRIBE
SUBSCRIBE

Celcuity

NEWS
FDA
FDA Weekly Review: Avadel, Eton, Pfizer, Celcuity and Others
FDA Weekly Review looks at the FDA’s actions related to drug approvals, IND approvals, designations and more. Here’s a look at what happened this week.
July 22, 2022
 · 
4 min read
 · 
Mark Terry
Business
Celcuity and Pfizer Enter Agreement for Breast Cancer Drug Following Positive Data
Clinical-stage biotech company Celcuity announced Thursday that it had entered into a global licensing agreement with Pfizer to develop and commercialize gedatolisib, the latter company’s first-in-class PI3K/mTOR inhibitor for the treatment of breast cancer.
April 9, 2021
 · 
3 min read
 · 
Brandon May
IN THE PRESS
Press Releases
Celcuity Inc. Schedules Release of Second Quarter 2024 Financial Results and Webcast/Conference Call
August 7, 2024
 · 
2 min read
BioMidwest
Celcuity To Participate in Jefferies Global Healthcare Conference
June 3, 2024
 · 
1 min read
Deals
Celcuity Announces Pricing of Underwritten Common Stock Offering
May 30, 2024
 · 
5 min read
Drug Development
Celcuity Inc. Announces Plan to Initiate a Phase 3 Clinical Trial for Gedatolisib as First-Line Treatment for HR+/HER2- Advanced Breast Cancer and Secures Approximately $62 Million Debt Financing
May 30, 2024
 · 
8 min read
Business
Celcuity Inc. Reports First Quarter Financial Results and Provides Corporate Update
May 15, 2024
 · 
11 min read
Business
Celcuity Inc. Schedules Release of First Quarter 2024 Financial Results and Webcast/Conference Call
May 8, 2024
 · 
1 min read
BioMidwest
Celcuity To Present at Upcoming Needham and Stifel Investor Conferences
April 4, 2024
 · 
2 min read
Business
Celcuity Inc. Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
March 27, 2024
 · 
13 min read
Business
Celcuity Inc. Schedules Release of Fourth Quarter and Full Year 2023 Financial Results and Webcast/Conference Call
March 20, 2024
 · 
1 min read
BioMidwest
Celcuity to Participate in Leerink Partners Global Biopharma Conference 2024
March 6, 2024
 · 
1 min read
Load More
JOBS